- Report
- October 2024
- 300 Pages
Global
From €3885EUR$3,995USD£3,219GBP
- Report
- August 2024
Global
From €4667EUR$4,799USD£3,867GBP
- Report
- October 2024
- 180 Pages
Global
From €4084EUR$4,200USD£3,384GBP
- Report
- February 2024
- 158 Pages
Global
From €5348EUR$5,500USD£4,432GBP
- Report
- February 2024
- 137 Pages
Global
From €4814EUR$4,950USD£3,989GBP
- Report
- February 2024
- 78 Pages
Global
From €3404EUR$3,500USD£2,820GBP
- Report
- June 2024
Global
From €4814EUR$4,950USD£3,989GBP
- Report
- October 2024
- 185 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- November 2024
- 182 Pages
Global
From €3447EUR$3,545USD£2,856GBP
€3830EUR$3,939USD£3,174GBP
- Report
- November 2024
- 184 Pages
Global
From €3447EUR$3,545USD£2,856GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 196 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 196 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 199 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 195 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 195 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 190 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 197 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 181 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 184 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
- Report
- October 2024
- 186 Pages
Global
From €3447EUR$3,545USD£2,857GBP
€3830EUR$3,939USD£3,174GBP
The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders.
Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists.
Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more